Bob Douglas named head of Synovate Healthcare
27 三月 2009
LONDON — International research firm Synovate has today announced the appointment of Bob Douglas, formerly head of Synovate Healthcare's global custom business, to the role of Global Head of Synovate Healthcare.
Throughout a healthcare research career spanning over 30 years, London-based Douglas has spent considerable time both agency and client side. Since joining Synovate Healthcare in 2004, Douglas set up the company's GCR (Global Client Relationships) programme for Healthcare and has been responsible for identifying best practice standards within key areas of research in partnership with Synovate's innovation teams.
In his new role, Douglas will assume overall responsibility for Synovate's healthcare unit, providing strategic and commercial industry specific leadership.
Reporting to Peter Huijboom, the Amsterdam-based CEO of Clients and Industries, Douglas will work in partnership with Synovate's geography leaders to drive healthcare research in local markets.
Former Synovate Healthcare CEO Michael Spedding was recently tapped for a new role within the group. As CEO he now has overall responsibility for the leadership of Synovate's businesses in Latin America & Iberia, North Asia, South Asia, China, Japan, Australia, New Zealand, Southern Europe, Central Europe, the Middle East and Africa.
Contact(s) for this press release
|
Joanne Humphrey
Marketing Manager Synovate UK |
|
|
Telephone: +44 20 3059 4808 |
|
Synovate Healthcare is Synovate's global specialist healthcare market research vertical, dedicated to delivering marketing insights to the pharmaceutical and healthcare industries.
For further details, visit www.synovate.com/healthcare.
About Synovate
Synovate, the market research arm of Aegis Group plc, generates consumer insights that drive competitive marketing solutions. The network provides clients with cohesive global support and a comprehensive suite of research solutions. Synovate employs over 6,400 staff across 62 countries.
For more information on Synovate visit www.synovate.com.